Track the Concord Biotech Limited stock price and the full insider trade history of the company, a listed issuer based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Concord Biotech Limited has published 9 insider filings. Market capitalisation: €110bn. The latest transaction was filed on 23 September 2024 (Sale). Among the most active insiders: UTPAL SHETH. Every trade is accessible without an account.
9
Insider Decl.
0
Thresholds
€24,948
2 ops.
Buy Volume
€2m
7 ops.
Sell Volume
10Σ signal
Buys €24,948€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,278 of 26,134 companies
60.6
score / 100
Value
33
Quality
88
FCF yld1.3%
Earn yld1.9%
EV/EBITDA32.6x
ROE14%
Gross mgn75%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.